FMP
NASDAQ
4.26 USD
0.6112 (14.34%)
Mr. Gerald W. Bruce
Healthcare
Biotechnology
https://www.virpaxpharma.com
NASDAQ
Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical nonsteroidal anti-inflammatory drug treatment for chronic osteoarthritis of the knee; Probudur, an injectable local anesthetic liposomal gel technology for postoperative pain management; and Envelta, a nanotechnology-based intranasal spray drug product candidate that enables the delivery of a metabolically labile peptide drug into the brain. The company...
0001708331
US9282511073
928251107
1055 Westlakes Drive
610 727 4597
US
7
Feb 17, 2021
0001708331
NASDAQ
Biotechnology
Healthcare
928251107
US9282511073
US
4.26
1.3
24.15k
4.99M
-
2.4-11.77
7.81
-
-
-
-
-0.36
-
https://www.virpaxpharma.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.